Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSOGEN: Effect of adalimumab on self-image and sexual functioning in moderate to severe anogenital psoriasis
2009-011625-13Phase 4Active
- Sponsor
- Abbott Laboratories
- Start
- Apr 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adalimumab in Anogenital Psoriasis, sponsored by Abbott Laboratories. Primary endpoint: Reduction of PASI and questionnaire scores. Started Apr 2009; status: active.
02
Drugs
03
Conditions
Anogenital Psoriasis
Beyond the preview
Go deeper on 2009-011625-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011625-13.